Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection

Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection

Abstract Severe pulmonary infection is a major threat to human health accompanied by substantial medical costs, prolonged inpatient requirements, and high mortality rates. New antimicrobial therapeutic strategies are urgently required to address the emergence of antibiotic resistance and persistent...

Full description

Bibliographic Details
Main Authors: Yue‐qing Zhou, Yun Shi, Ling Yang, Yu‐fen Sun, Yu‐fei Han, Zi‐xian Zhao, Yu‐jia Wang, Ying Liu, Yu Ma, Ting Zhang, Tao Ren, Tina P Dale, Nicholas R Forsyth, Fa‐guang Jin, Jie‐ming Qu, Wei Zuo, Jin‐fu Xu
Format: Article
Language:English
Published: Springer Nature 2020-01-01
Series:EMBO Molecular Medicine
Subjects:
antimicrobial peptide
distal airway stem cells
pulmonary infection
transplantation
Online Access:https://doi.org/10.15252/emmm.201810233

Internet

https://doi.org/10.15252/emmm.201810233

Similar Items